Search for: "MERCK " Results 81 - 100 of 3,321
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Apr 2023, 5:50 am by Kevin Klyman
As Bloomberg reported today, Germany has also proposed export controls on the sale of chemicals for semiconductor production to China; the German chemical company Merck has a hand in the production of nearly every chip as a key supplier of chemicals like photoresists that are used to print patterns onto semiconductors. [read post]
18 Apr 2023, 9:05 pm by Dan Flynn
USDA reports testing one vaccine from Zoetis, one from Merck Animal Health, and two of its own from the Agriculture Research Service. [read post]
18 Apr 2023, 12:54 pm by Milavetz Law, P.A.
Some injuries are not immediately apparent, and if you have a spinal cord injury, even slight movements can cause permanent paralysis that could have been prevented, according to the Merck Manual.If anyone is injured, call 911 and dispatch emergency medical services. [read post]
12 Apr 2023, 3:00 am by John Jenkins
  Nevertheless, that’s the kind of claim that the Chancery Court recently addressed in Merck […] [read post]
The judge reviewed the national case law on selections/deletions from multiple lists (Merck v Shionogi [2016] EWHC 2989 (Pat), Nokia v IPCom [2012] EWCA Civ 567 and GlaxoSmithKline v Wyeth [2016] EWHC 1045 (Pat)) and the EPO cases reviewed therein and in the EPO Case Law Book. [read post]
In November 2020, the BRPTO rejected without further administrative appeal a patent application filed by Merck Sharp & Dohme (MSD) on January 8, 2009, after the applicant failed to respond to an office action and later to appeal the decision rejecting the application. [read post]
24 Mar 2023, 6:28 am by Benjamin Goh
Though the GC previously held that even the sale of goods exclusively in pharmacies does not mean that they are medicinal products (T‑802/16 - Endoceutics/EUIPO – Merck), still the fact that a product is sold only in pharmacies is a relevant factor when classifying a product as medicinal. [read post]
4 Mar 2023, 8:45 pm by Patent Docs
Irving of Finnegan Henderson Farabow Garrett & Dunner, Sarah Hooson of Merck Sharp & Dohme, Krista Kostiew of Unilever, and Xiaoguang Michelle Gao of Eli Lilly and Company will guide patent counsel on recent trends and developments in patent practice; examine the Supreme Court, Federal Circuit, and PTAB cases from the past year; and discuss some of the key developments and strategies.... [read post]
2 Mar 2023, 7:28 am by Thomas Sheridan
Gardasil, the leading vaccine against human papillomavirus (HPV) first introduced by Merck & Co. in 2006, has recently come under fire as a growing number of lawsuits are filed against Merck. [read post]
11 Feb 2023, 7:17 pm by Patent Docs
MacAlpine of Finnegan Henderson Farabow Garrett & Dunner, and Sarah Hooson of Merck Sharp & Dohme will guide patent counsel on recent Orange Book developments; discuss Orange Book listing practices and the implications for patent prosecution, listing, and litigation; and examine contemporary thought about Form 3542 and pitfalls to avoid.... [read post]
8 Feb 2023, 7:36 am by Kaufman Dolowich Voluck
The post Partner Eric Stern quoted, Law 360, “Merck War Exclusion Appeal Puts Focus On Policy Language,” 2-6-2023 appeared first on Kaufman Dolowich Voluck LLP. [read post]
11 Jan 2023, 3:18 pm by ARUNDHATI PARMAR - MEDCITY NEWS
Morgan Healthcare Conference in which Merck's chief strategy officer, a healthcare leader from Goldman Sachs, an investment executive, and a senior medical devices executive from Medtronic weighed in on trends the life sciences industry can expect to see in 2023. [read post]
Merck Sharp & Dohme (C-119/22) made by the Finnish Market Court in February 2022 (see here for an English translation of the referring decision) and Merck Sharp & Dohme v. [read post]
26 Nov 2022, 3:45 am by jonathanturley
., Ford, Jeep, Kyndryl, Merck & Co. and Novartis AG all issued statements about halting Twitter ads or were reported and confirmed as doing so. [read post]
16 Nov 2022, 6:09 am by Anastasiia Kyrylenko
Merck also asked the Ministry of Health to deny Teva’s marketing authorisation to a medicine called “Caspofungin-Teva” on the ground that it infringes Merck’s rights in patent No 55409.Merck’s patent was filed in Ukraine on April 15, 1997. [read post]